title: Integrating analysis reveals microRNA-mediated pathway crosstalk among Crohn's disease, ulcerative colitis and colorectal cancer.
abstract: Inflammatory bowel disease (IBD), which can increase the risk of colorectal cancer (CRC), includes two primary subtypes, ulcerative colitis (UC) and Crohn's disease (CD). Although several individual genes involved in inflammation or cancer characterization have been identified, it is still difficult to elucidate functional relationship details between the molecules underlying pathogenesis at the system level. The global effect of miRNAs on genes or their involved functions is also poorly understood. We first integrated genome-wide gene expression profiles and biological pathway information to explore the underlying associations among UC, CD and CRC at the function and gene level. After identifying the pathways regulated by miRNAs, a global map of miRNA-mediated pathway crosstalk shared by the three diseases was further constructed to vertically explain the links of three level alterations. The three types of diseases have close associations with each other at the levels of function, gene and miRNA regulation. Several key biological pathways are involved in the three diseases, related to the immune system and inflammation, metabolism, or cell proliferation and apoptosis etc. Moreover, miRNAs exhibit dominant effects on multiple pathways. It is worth noting that UC shows relatively close associations with CD and CRC at the three levels. Finally, the miRNAs could mediate the crosstalk within or between pathways. For example, hsa-miR-125b, hsa-miR-335 and hsa-miR-155 mediated the crosstalk between three metabolic pathways. The crosstalk within the Toll-like receptor signaling pathway could be mediated by hsa-miR-124, hsa-miR-146a and hsa-mir-221/222. Our results make sense for the prevention and treatment of intestinal-related chronic inflammation or cancer.
authors.affiliation: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China. lixia@hrbmu.edu.cn xujuanbiocc@ems.hrbmu.edu.cn.
authors.forename: Jing
authors.initials: J
authors.lastname: Bai
authors.forename: Yongsheng
authors.initials: Y
authors.lastname: Li
authors.forename: Tingting
authors.initials: T
authors.lastname: Shao
authors.forename: Zheng
authors.initials: Z
authors.lastname: Zhao
authors.forename: Yuan
authors.initials: Y
authors.lastname: Wang
authors.forename: Aiwei
authors.initials: A
authors.lastname: Wu
authors.forename: Hong
authors.initials: H
authors.lastname: Chen
authors.forename: Shengli
authors.initials: S
authors.lastname: Li
authors.forename: Chunjie
authors.initials: C
authors.lastname: Jiang
authors.forename: Juan
authors.initials: J
authors.lastname: Xu
authors.forename: Xia
authors.initials: X
authors.lastname: Li
mesh_terms: D017209:Apoptosis / Q000235:genetics; D049109:Cell Proliferation / Q000235:genetics; D003093:Colitis, Ulcerative / Q000235:genetics*; D015179:Colorectal Neoplasms / Q000209:etiology* / Q000235:genetics*; D003424:Crohn Disease / Q000235:genetics*; D020869:Gene Expression Profiling / Q000379:methods; D006801:Humans; D007249:Inflammation / Q000235:genetics; D035683:MicroRNAs / Q000235:genetics*; D012306:Risk; D015398:Signal Transduction / Q000235:genetics; D059467:Transcriptome / Q000235:genetics
chemical_list: D035683:MicroRNAs